Showing results (231-240 of 310) with videos related to

Sort By:
Pageof 31
Inorganic Chemistry|October 27, 2012
Magnetic and structural studies of the multifunctional material SrFe(0.75)Mo(0.25)O(3-δ)M Retuerto, M-R Li, Y B Go, et al.
Journal of Substance Abuse Treatment|November 29, 2005
Impact of drug treatment on subsequent sexual risk behavior in a multisite cohort of drug-using women: a report from the Women's Interagency HIV StudyMary H Latka, Tracey E Wilson, Judith A Cook, et al.
BMC Women'S Health|December 9, 2022
Providers' perspectives on the reproductive decision-making of BRCA-positive womenE S Dason, L Drost, E M Greenblatt, et al.
AIDS (London, England)|November 27, 2013
Common clinical conditions - age, low BMI, ritonavir use, mild renal impairment - affect tenofovir pharmacokinetics in a large cohort of HIV-infected womenSanjiv M Baxi, Ruth M Greenblatt, Peter Bacchetti, et al.
The Journal of Infectious Diseases|June 14, 2012
Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infectionMaria C Villacres, Naoko Kono, Wendy J Mack, et al.
AIDS (London, England)|December 4, 2008
Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected womenNancy A Hessol, Elizabeth A Holly, Jimmy T Efird, et al.
Plos One|January 10, 2018
Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trialSanjiv M Baxi, Eric Vittinghoff, Peter Bacchetti, et al.
Microbiome|January 22, 2016
Correlation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infectionSushma K Cribbs, Karan Uppal, Shuzhao Li, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 11, 1999
Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study GroupL S Massad, K A Riester, K M Anastos, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2011
Atazanavir concentration in hair is the strongest predictor of outcomes on antiretroviral therapyMonica Gandhi, Niloufar Ameli, Peter Bacchetti, et al.
Pageof 31